K
65
2
ABT
69
-5
IPG
53
3
CINF
45
2
DE
63
5
SJM
23
-5
KIM
48
-6
MAT
49
2
XRX
34
2
KMI
53
2
AAPL
65
3
NAVI
47
6
AIV
41
-3
VZ
40
-2
CMG
57
-3
FDX
40
3
NI
67
2
WFC
79
5
NWSA
88
10
PSX
42
5
K
65
2
ABT
69
-5
IPG
53
3
CINF
45
2
DE
63
5
SJM
23
-5
KIM
48
-6
MAT
49
2
XRX
34
2
KMI
53
2
AAPL
65
3
NAVI
47
6
AIV
41
-3
VZ
40
-2
CMG
57
-3
FDX
40
3
NI
67
2
WFC
79
5
NWSA
88
10
PSX
42
5
Financhill
Back

Electromed 10K Form

Buy
76

ELMD
Electromed

Last Price:
$31.68
Seasonality Move:
3.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ELMD News And Ratings

See the #1 stock for the next 7 days that we like better than ELMD

ELMD Financial Statistics

Sales & Book Value

Annual Sales: $54.7M
Cash Flow: $2.9M
Price / Cash Flow: 26.37
Annual Sales: $5.10
Price / Book: 6.26

Profitability

EPS (TTM): 0.75000
Net Income (TTM): $6.8M
Gross Margin: $41.7M
Return on Equity: 15.91%
Return on Assets: 13.57%

Electromed Earnings Forecast

Key Electromed Financial Ratios

  • The Gross Profit Margin over the past 17 years for ELMD is 76.26%.
  • The Selling, General & Administrative Expenses for ELMD have been equal to 63.03% of Gross Profit Margin.
  • The Research & Development expenses have been 1.20% of Revenue.
  • The Interest Expense is 3.62% of Operating Income.
  • The Net Earning history of ELMD is 9.41% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 7 years.

Electromed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ELMD
CUSIP: 285409
Website: smartvest.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.1
Quick Ratio: 4.68

Price-to-Earnings

Trailing P/E Ratio: 54.98
Forward P/E Ratio: 0

ELMD Technical Analysis vs Fundamental Analysis

Buy
76
Electromed (ELMD) is a Buy

Is Electromed a Buy or a Sell?

  • Electromed stock is rated a Buy
    The current Electromed [ELMD] share price is $31.89. The Score for ELMD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.